Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 3562 composition records across product categories including Construction and building materials, Specialty occupational products, Cleaning and safety.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of ANHYDROUS TRISODIUM CITRATE in our catalog (epa_cpdat).
Products
3,562
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 3562 composition records across product categories including Construction and building materials, Specialty occupational products, Cleaning and safety. EPA CPDat classifies this chemical for functional uses including Chelating agent, pH regulating agent, Deodorizer.
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION; Maximum daily exposure: 22 mg
US
FDA
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: INTRABURSAL; Dosage form: INJECTION; Potency: 1 %w/v
US
FDA
Route: INTRALESIONAL; Dosage form: INJECTION; Maximum daily exposure: 22 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 792 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 240 mg
US
FDA
Route: INTRAVENOUS; Dosage form: CONCENTRATE; Maximum daily exposure: 24 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 792 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 240 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 24 mg
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION, CONCENTRATE; Maximum daily exposure: 24 mg
US
FDA
Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 8 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, EFFERVESCENT; Potency: 935 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 4000 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: 48 mg/5ml
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 320 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 240 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 21 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 47 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 156 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 720 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 72.5 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 15 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SUSPENSION; Maximum daily exposure: 2 mg
US
FDA
Route: SOFT TISSUE; Dosage form: INJECTION; Maximum daily exposure: 22 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 0.94 %w/v
US
FDA
Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 4 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 36 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 4 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Potency: 0.08 %w/w
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.1 %w/v
US
FDA
FDA NDC lists this ingredient in 1 active drug products and 1 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.
US
USDA FoodData Central
Observed in 1 USDA branded foods including 1.75L Bloody Mary with Horseradish (MED).